New Drug Approvals Archive
New Drug Approvals: January 2007
| January 12 | Olux-E (clobetasol propionate) Foam Date of Approval: January 12, 2007 Company: Stiefel Laboratories, Inc. Treatment for Psoriasis, Eczema Olux-E is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older. Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema |
| January 16 | Lialda (mesalamine) Delayed Release Tablets Date of Approval: January 16, 2007 Company: Shire plc Treatment for Ulcerative Colitis Lialda is a once-daily oral formulation of mesalamine indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis. Lialda Shire plc - Treatment for Ulcerative Colitis |
| January 30 | Yaz (drospirenone and ethinyl estradiol) Tablets Company: Berlex, Inc. Treatment for Acne FDA Approves New Indication for Yaz to Treat Acne |
| January 30 | Vidaza (azacitidine)
New Dosage Form Approved: January 26, 2007 Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration |
| January 31 | Flector (diclofenac epolamine) Topical Patch Date of Approval: January 31, 2007 Company: Institut Biochimique SA Treatment for Pain Flector is a transdermal patch formulation of the nonsteroidal anti-inflammatory drug diclofenac, indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions. Flector Approved - Institut Biochimique SA - Treatment for acute pain due to minor strains, sprains, and contusions. |
New Drug Approvals Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec
